NCT07663006Not yet recruiting
Breast and Cervical Cancer Stigma in Rwanda
Assessing Breast and Cervical Cancer Stigma and Piloting a Mitigating Intervention in Rwanda
Source: ClinicalTrials.gov · Last updated 23 Jun 2026
Brief summary (registry, in English)
This study aims to assess breast and cervical cancer stigma and pilot a multi-modal intervention to mitigate stigma among patients, caregivers, and community health workers in Rwanda. The elements include resilience training (patient), support group (caregivers), or exposure to survivors by video and in-person (patient, caregivers, and community health workers), and educational curriculum (community health workers).
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 1116 (estimated)
- First submitted
- 22 May 2026
- Start date
- 1 Nov 2026
- Primary completion date
- 1 Dec 2027
- Lead sponsor
- Dana-Farber Cancer Institute
- Diseases
- Cervical cancer
- NCT number
- NCT07663006
What you commit to
- Study type: Interventional
- Planned participants: 1116
- From 1 Nov 2026 to the primary completion date, 1 Dec 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Pregnant women Note: Determination of ability to consent will be made by trained study staff prior to enrollment
- Interpersonal interviews and surveys:
- Caregivers of the potential patients will be identified from the potential patients. Potential patients will be identified by the clinical team from physical and electronic registries of patients. Potential participants will be screened for eligibility by the study research assistant.
- Pregnant women Note: Determination of ability to consent will be made by trained study staff prior to enrollment
- Institutional Focus group:
- An official participation letter will be sent from BL2TH to leaders of the preselected facilities. Interested participants will be encouraged to contact the study team. Potential participants will be invited by their hospital/center leadership and screened for eligibility by the study research assistant.
- Pregnant women Note: Determination of ability to consent will be made by trained study staff prior to enrollment
- Institutional surveys:
- Formal participation invitation will be sent to the Rwanda Medical and Dental Council, National Council of Nurses and Midwives, and the Rwanda Allied Health Professions Council. Potential participants will be screened for eligibility electronically and informed consent obtained electronically.
- Pregnant women Note: Determination of ability to consent will be made by trained study staff prior to enrollment
- Aim 2 Inclusion and Exclusion Criteria Aim 2 Intervention pilot (patient, caregivers and community health workers)
- Patient and Caregiver Pilot:
- Pregnant women Note: Determination of ability to consent will be made by trained study staff prior to enrollment
- Community Health Worker Pilot:
Other
- Unwilling or Unable to consent to participation.
- Unable to comprehend study language (Kinyarwanda or English)
- Individuals who are not yet adults (infants, children, teenagers)
- Prisoners
- Unwilling or Unable to consent to participation.
- Unable to comprehend study language (Kinyarwanda or English)
- Individuals who are not yet adults (infants, children, teenagers)
- Prisoners
- Unwilling or Unable to consent to participation.
- Unable to comprehend study language (Kinyarwanda or English)
- Individuals who are not yet adults (infants, children, teenagers)
- Prisoners
- Unwilling or Unable to consent to participation.
- Unable to comprehend study language (Kinyarwanda or English)
- Individuals who are not yet adults (infants, children, teenagers)
- Prisoners
- Unwilling or Unable to consent to participation.
- Unable to comprehend study language (Kinyarwanda or English)
- Individuals who are not yet adults (infants, children, teenagers)
- Prisoners
- Unwilling or Unable to consent to participation
- Unable to comprehend study language (Kinyarwanda or English)
- Individuals who are not yet adults (infants, children, teenagers)
- Prisoners
- Pregnant women
Who the study is looking for
- Patients with pathologically confirmed breast or cervical cancer
- Patients receiving treatment at BCCOE during the study period
- Age 18 and over
- Ability to provide informed consent
- Ability to participate in interview or surveys in English or Kinyarwanda
- Caregiver (including spouses, children, family members or other individuals as designated by patients) of patients with pathologically confirmed breast or cervical cancer who are actively receiving treatment at BCCOE during the study period
- Age 18 and over
- Ability to provide informed consent
- Ability to participate in interview or surveys in English or Kinyarwanda
- Healthcare Worker
- Working in a preselected health center, district hospital, provincial hospital in the Northern Province
- Age 18 or older
- Ability to provide informed consent
- Ability to participate in interview or surveys in English or Kinyarwanda
- Healthcare Worker
- Registered with relevant professional organization in Rwanda
- Age 18 or older
- Ability to provide informed consent
- Ability to participate in surveys in English or Kinyarwanda
- Patients with pathologically confirmed breast cancer who are actively receiving curative-intent treatment at BCCOE during the study period and a designated caregiver
- Patients getting systemic neoadjuvant chemotherapy who are expected in the clinic on a 3-week cycle
- Patients who have at least 4 cycles of therapy remaining
- Age 18 and over
- Ability to provide informed consent
- Ability to participate in pilot, interview, and surveys in English or Kinyarwanda
- Community Health Worker registered with relevant healthcare facilities in Northern Rwanda
- Age 18 or older
- Willing to engage in activities related to breast and cervical cancer and to support survivors
- Ability to provide informed consent
- Ability to participate in pilot, interview, and surveys in English or Kinyarwanda
Criteria the registry did not label
- Aim 1 Inclusion and Exclusion Criteria Aim 1 Interviews and Surveys
- Individual interviews and surveys:
- Potential patients will be identified by the clinical team from physical and electronic registries of patients. Potential participants will be screened for eligibility by the study research assistant.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Butaro Level 2 Teaching Hospital (BL2TH), Ministry of Health Coordinator of this site? Confirm its status | Butaro | Rwanda | Unknown status |
| University of Global Health Equity (UGHE) Coordinator of this site? Confirm its status | Butaro | Rwanda | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.